Found 5 matching trials
Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
PHASE3The goal of this clinical trial is to evaluate the efficacy of investigator...
Location
Fudan University Shanghai Cancer Center
Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.
PHASE2To assess the efficacy and safety of adebrelimab in combination with apatin...
Location
The First Affiliated Hospital of Henan University of Science and Technology
A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
PHASE3The purpose of this study was to evaluate the efficacy and safety of tislel...
Location
Henry Ford Hospital
Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
PHASE2The study aimed to evaluate the efficacy and safety of sitravatinib in comb...
Location
Anhui Provincial Hospital South Brance
A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC
PHASE2This is a prospective, single-center, single-arm clinical study. It aims to...
Location
Multiple Locations